Search

Your search keyword '"P. Saddier"' showing total 68 results

Search Constraints

Start Over You searched for: Author "P. Saddier" Remove constraint Author: "P. Saddier"
68 results on '"P. Saddier"'

Search Results

1. Breaking of a floating particle raft by water waves

2. A Bayesian theory of market impact

6. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

7. Nocturnal Melatonin Excretion is Decreased in Patients With Migraine Without Aura Attacks Associated With Menses

8. Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort

9. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group

10. [Proposal of guidelines for the set-up of pharmaco-epidemiologic studies in drug surveillance]

11. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study

13. Fickle or Flexible?

14. Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world

15. SEIN-WS-11 Macrobiopsie sous echographie : luxe, utile, necessaire ou indispensable ?

16. 3007 Herpes zoster in solid tumor and hematologic malignancy patients – a cohort study in a managed care organization

17. Evolution de la senologie en cabinet liberal

18. Fickle or Flexible?: Assessing Paratransit Reliability with Smartphones in Accra, Ghana

20. Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records

21. Mapping the Jitney Network with Smartphones in Accra, Ghana

22. Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody

23. Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study

25. Adaptation of a previously validated vaccination report card for use in adult vaccine clinical trials to align with the 2007 FDA Toxicity Grading Scale Guidance

26. Work and productivity loss related to herpes zoster

27. Nocturnal Melatonin Excretion is Decreased in Patients With Migraine Without Aura Attacks Associated With Menses

30. Immunocompromised Status of Patients with Hematologic and Solid Tumor Malignancies: Construction of a Practical Algorithm.

31. Cost of Varicella in France: A Study in Day Care Centers

32. Risk of cancer from azathioprine therapy in multiple sclerosis

33. Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records.

34. Incident autoimmune conditions among males receiving quadrivalent human papillomavirus vaccine in the United States.

35. Safety of 9-valent human papillomavirus vaccine administered to males and females in routine use.

36. Vaccine initiation and 3-dose series completion of 4vHPV vaccine among US insured males 2012-2016.

37. Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention.

38. Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study.

39. Herpes zoster vaccine live: A 10 year review of post-marketing safety experience.

40. Impact of vaccination on the epidemiology of varicella: 1995-2009.

41. Complications of herpes zoster in cancer patients.

42. Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study.

43. Safety of Zostavax™--a cohort study in a managed care organization.

44. Herpes zoster recurrences more frequent than previously reported.

45. Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults.

46. Health care utilization and cost burden of herpes zoster in a community population.

47. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting.

48. Lack of association between age at varicella vaccination and risk of breakthrough varicella, within the Northern California Kaiser Permanente Medical Care Program.

49. Postherpetic neuralgia: epidemiology, pathophysiology and management.

50. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.

Catalog

Books, media, physical & digital resources